<DOC>
	<DOCNO>NCT00514865</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy ONO-2333Ms patient Recurrent Major Depressive Disorder</brief_summary>
	<brief_title>Placebo-Controlled Study ONO-2333Ms Patients With Recurrent Major Depressive Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Diagnosed recurrent major depressive disorder Patients treatment resistance depression History alcohol abuse/dependence , substance abuse/dependence within 6 month Has clinically significant unstable medical condition Has significant risk suicide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>ONO-2333Ms</keyword>
	<keyword>Major Depressive Disorder</keyword>
</DOC>